Titre : Gui

Gui : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multiple Chronic Conditions
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gui : Questions médicales les plus fréquentes", "headline": "Gui : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gui : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gui" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Magnoliopsida", "url": "https://questionsmedicales.fr/mesh/D019684", "about": { "@type": "MedicalCondition", "name": "Magnoliopsida", "code": { "@type": "MedicalCode", "code": "D019684", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Loranthaceae", "alternateName": "Loranthaceae", "url": "https://questionsmedicales.fr/mesh/D028183", "about": { "@type": "MedicalCondition", "name": "Loranthaceae", "code": { "@type": "MedicalCode", "code": "D028183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.735.249" } } }, { "@type": "MedicalWebPage", "name": "Viscaceae", "alternateName": "Viscaceae", "url": "https://questionsmedicales.fr/mesh/D028163", "about": { "@type": "MedicalCondition", "name": "Viscaceae", "code": { "@type": "MedicalCode", "code": "D028163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.735.888" } } } ], "about": { "@type": "MedicalCondition", "name": "Gui", "alternateName": "Mistletoe", "code": { "@type": "MedicalCode", "code": "D014784", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jutta Huebner", "url": "https://questionsmedicales.fr/author/Jutta%20Huebner", "affiliation": { "@type": "Organization", "name": "Klinik Für Innere Medizin II, Hämatologie Und Onkologie, Universitätsklinikum Jena, Jena, Germany." } }, { "@type": "Person", "name": "Jin Chen", "url": "https://questionsmedicales.fr/author/Jin%20Chen", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China." } }, { "@type": "Person", "name": "Ling Zhang", "url": "https://questionsmedicales.fr/author/Ling%20Zhang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, 666303, Yunnan, China. zhangl@xtbg.org.cn." } }, { "@type": "Person", "name": "David M Watson", "url": "https://questionsmedicales.fr/author/David%20M%20Watson", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Peiying Yang", "url": "https://questionsmedicales.fr/author/Peiying%20Yang", "affiliation": { "@type": "Organization", "name": "Departments of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Texas, Houston, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparing the association between multiple chronic conditions, multimorbidity, frailty, and survival among older patients with cancer.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35786369", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jgo.2022.06.011" } }, { "@type": "ScholarlyArticle", "name": "An Assessment of Patient Portal Messaging Use by Patients With Multiple Chronic Conditions Living in Rural Communities: Retrospective Analysis.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37526967", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/44399" } }, { "@type": "ScholarlyArticle", "name": "Adjustment for Social Risk Factors in a Measure of Clinician Quality Assessing Acute Admissions for Patients With Multiple Chronic Conditions.", "datePublished": "2023-03-03", "url": "https://questionsmedicales.fr/article/36897581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamahealthforum.2023.0081" } }, { "@type": "ScholarlyArticle", "name": "Prevalence and determinants of multiple chronic conditions (MCC) among young adults in Indian households: an analysis of NFHS-5.", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/38835054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41043-024-00560-0" } }, { "@type": "ScholarlyArticle", "name": "Relationship between Treatment Burden, Health Literacy, and Medication Adherence in Older Adults Coping with Multiple Chronic Conditions.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37629691", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/medicina59081401" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Gui", "item": "https://questionsmedicales.fr/mesh/D014784" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gui - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gui", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gui", "description": "Comment diagnostiquer une intoxication au gui ?\nQuels tests sont utilisés pour le gui en médecine ?\nQuels signes cliniques indiquent une réaction au gui ?\nLe gui peut-il être détecté par imagerie ?\nComment différencier le gui des autres plantes ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gui", "description": "Quels sont les symptômes d'une intoxication au gui ?\nLe gui provoque-t-il des allergies ?\nQuels effets secondaires sont associés au gui ?\nLe gui peut-il causer des troubles respiratoires ?\nQuels symptômes sont liés à l'utilisation thérapeutique du gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gui", "description": "Comment prévenir l'intoxication au gui ?\nLe gui est-il dangereux pour les animaux ?\nComment identifier le gui dans la nature ?\nQuelles précautions prendre lors de la récolte du gui ?\nLe gui peut-il être cultivé en toute sécurité ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gui", "description": "Comment traiter une intoxication au gui ?\nLe gui est-il utilisé en oncologie ?\nQuels médicaments interagissent avec le gui ?\nLe gui peut-il être utilisé en phytothérapie ?\nQuels sont les traitements alternatifs au gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gui", "description": "Quelles complications peuvent survenir avec le gui ?\nLe gui peut-il causer des problèmes cardiaques ?\nQuels sont les risques d'une surconsommation de gui ?\nLe gui peut-il affecter la grossesse ?\nQuelles sont les conséquences d'une réaction allergique au gui ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gui", "description": "Qui est à risque d'intoxication au gui ?\nLes personnes allergiques au gui sont-elles plus à risque ?\nLe risque d'intoxication varie-t-il selon la région ?\nLes personnes âgées sont-elles plus vulnérables au gui ?\nLes utilisateurs de médecines alternatives sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D014784?mesh_terms=Multiple+Chronic+Conditions&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication au gui ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'intoxication se diagnostique par l'examen des symptômes cliniques et l'historique d'exposition." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le gui en médecine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent être effectués pour évaluer les niveaux de toxines en cas d'intoxication." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une réaction au gui ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des nausées, des vomissements, des troubles respiratoires et des convulsions." } }, { "@type": "Question", "name": "Le gui peut-il être détecté par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, le gui ne peut pas être détecté par imagerie, mais ses effets peuvent l'être indirectement." } }, { "@type": "Question", "name": "Comment différencier le gui des autres plantes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le gui se distingue par ses baies blanches et sa croissance sur d'autres arbres, souvent en hiver." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication au gui ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges." } }, { "@type": "Question", "name": "Le gui provoque-t-il des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques au gui, comme des éruptions cutanées." } }, { "@type": "Question", "name": "Quels effets secondaires sont associés au gui ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des effets neurologiques." } }, { "@type": "Question", "name": "Le gui peut-il causer des troubles respiratoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ingestion de gui peut entraîner des difficultés respiratoires dans les cas graves." } }, { "@type": "Question", "name": "Quels symptômes sont liés à l'utilisation thérapeutique du gui ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets comme la fatigue, des maux de tête et des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir l'intoxication au gui ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des baies de gui et éduquez-vous sur les plantes toxiques." } }, { "@type": "Question", "name": "Le gui est-il dangereux pour les animaux ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est toxique pour de nombreux animaux, notamment les chiens et les chats." } }, { "@type": "Question", "name": "Comment identifier le gui dans la nature ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le gui se reconnaît par ses feuilles ovales et ses baies blanches, souvent sur des arbres." } }, { "@type": "Question", "name": "Quelles précautions prendre lors de la récolte du gui ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Portez des gants et évitez le contact direct avec la sève pour prévenir les irritations." } }, { "@type": "Question", "name": "Le gui peut-il être cultivé en toute sécurité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais il faut suivre des pratiques de culture appropriées pour éviter les risques d'intoxication." } }, { "@type": "Question", "name": "Comment traiter une intoxication au gui ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'évacuation du contenu gastrique et des soins symptomatiques en milieu hospitalier." } }, { "@type": "Question", "name": "Le gui est-il utilisé en oncologie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est parfois utilisé comme traitement complémentaire en oncologie, bien que son efficacité soit débattue." } }, { "@type": "Question", "name": "Quels médicaments interagissent avec le gui ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le gui peut interagir avec des anticoagulants et d'autres médicaments, nécessitant une prudence." } }, { "@type": "Question", "name": "Le gui peut-il être utilisé en phytothérapie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui est utilisé en phytothérapie pour ses propriétés supposées, mais avec précaution." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs au gui ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs incluent des remèdes à base de plantes, mais leur efficacité varie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le gui ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles gastro-intestinaux graves et des réactions allergiques sévères." } }, { "@type": "Question", "name": "Le gui peut-il causer des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une intoxication sévère au gui peut entraîner des arythmies cardiaques et d'autres problèmes." } }, { "@type": "Question", "name": "Quels sont les risques d'une surconsommation de gui ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des symptômes graves, y compris des convulsions et un coma." } }, { "@type": "Question", "name": "Le gui peut-il affecter la grossesse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le gui peut être dangereux pendant la grossesse et doit être évité par précaution." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une réaction allergique au gui ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure un choc anaphylactique, nécessitant une intervention médicale urgente." } }, { "@type": "Question", "name": "Qui est à risque d'intoxication au gui ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants et les animaux domestiques sont particulièrement à risque d'intoxication au gui." } }, { "@type": "Question", "name": "Les personnes allergiques au gui sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies aux plantes sont plus à risque." } }, { "@type": "Question", "name": "Le risque d'intoxication varie-t-il selon la région ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines régions ont une plus grande prévalence de gui, augmentant le risque d'intoxication." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables au gui ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets toxiques du gui." } }, { "@type": "Question", "name": "Les utilisateurs de médecines alternatives sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ceux qui utilisent le gui sans supervision médicale peuvent être à risque d'intoxication." } } ] } ] }

Sources (10000 au total)

Comparing the association between multiple chronic conditions, multimorbidity, frailty, and survival among older patients with cancer.

The high prevalence of multiple chronic conditions (MCC), multimorbidity, and frailty may affect treatment and outcomes for older adults with cancer. The goal of this study was to use three conceptual... Using Medicare claims data linked with the 2012-2016 Ohio Cancer Incidence Surveillance System we identified older adults with incident primary cancer sites of breast, colorectal, lung, or prostate (n... Lung cancer patients had the highest levels of MCC, multimorbidity, and frailty. There was a positive association between all three measures and a greater hazard of death after adjusting for age, sex ... The MCC, multimorbidity, and frailty indices performed similarly well in predicting mortality among a large cohort of older cancer patients. However, there were notable differences by cancer type. Thi...

An Assessment of Patient Portal Messaging Use by Patients With Multiple Chronic Conditions Living in Rural Communities: Retrospective Analysis.

Patient portals can facilitate the delivery of health care services and support self-management for patients with multiple chronic conditions. Despite their benefits, the evidence of patient portal us... This study aimed to explore the factors associated with portal messaging use by rural patients.... We assessed patient portal use among patients with ≥1 chronic diagnoses who sent or received messages via the Epic MyChart (Epic Systems Corporation) portal between January 1, 2015, and November 9, 20... A total of 65,178 patients (n=38,587, 59.2% female and n=21,454, 32.92% Black) were included in the final data set, of which 38,380 (58.88%) sent at least 1 message via the portal during the 7-year st... Patients' use of the portal to send messages to providers was incrementally related to their number of diagnoses. As the number of chronic diagnoses increased, so did portal messaging use. Patients of...

Adjustment for Social Risk Factors in a Measure of Clinician Quality Assessing Acute Admissions for Patients With Multiple Chronic Conditions.

Adjusting quality measures used in pay-for-performance programs for social risk factors remains controversial.... To illustrate a structured, transparent approach to decision-making about adjustment for social risk factors for a measure of clinician quality that assesses acute admissions for patients with multipl... This retrospective cohort study used 2017 and 2018 Medicare administrative claims and enrollment data, 2013 to 2017 American Community Survey data, and 2018 and 2019 Area Health Resource Files. Patien... Social risk factors included low Agency for Healthcare Research and Quality Socioeconomic Status Index, low physician-specialist density, and Medicare-Medicaid dual eligibility.... Number of acute unplanned hospital admissions per 100 person-years at risk for admission. Measure scores were calculated for MIPS clinicians with at least 18 patients with MCCs assigned to them.... There were 4 659 922 patients with MCCs (mean [SD] age, 79.0 [8.0] years; 42.5% male) assigned to 58 435 MIPS clinicians. The median (IQR) risk-standardized measure score was 38.9 (34.9-43.6) per 100 ... This cohort study demonstrated that adjustment for social risk factors in outcome measures requires weighing high-stake, competing concerns. A structured approach that includes evaluation of conceptua...

Prevalence and determinants of multiple chronic conditions (MCC) among young adults in Indian households: an analysis of NFHS-5.

Multiple chronic conditions (MCC) are defined as the presence of two or more chronic conditions, that significantly impact health status, functional capacity, quality of life, and overall healthcare m... Data used in this study were drawn from the fifth round of the National Family Health Survey (NFHS) conducted in 2019-21. Data sets of men (15-54 years) and women (15-49 years) were used for the study... A prevalence of 5.5% of MCC in adults emerged from our study. Logistic regression analysis identified that younger age, males (AOR 0.36 (0.33-0.39)), urban areas (AOR 1.11 (1.02-1.17)) as the place of... A 5% prevalence of MCC specifically obesity, substance use, and hypertension calls for integrated efforts aiming at behavior change, and regulatory efforts to prevent further increase of MCC among you...

Obesity, multiple chronic conditions, and the relationship with physical function: Data from the national health and aging trends survey.

The population of older adults living with multiple chronic conditions (MCC) continues to grow. MCC is independently associated with functional limitation and obesity. The aim of our study was to eval... We analyzed cross-sectional survey data from the National Health and Aging Trends Survey (NHATS) 2011 baseline data, a nationally representative Medicare beneficiary cohort of adults in the United Sta... In the 6,600 participants, the prevalence of concurrent obesity and MCC was 30.4%. Of those with obesity, the prevalence of MCC was 84.0%, and were more likely to have MCC (adjusted OR: 2.17, 95% CI 1... We found that individuals with obesity is strongly associated with MCC and that functional limitations and frailty status have a greater association with having MCC than individuals with obesity witho...

Safeguarding survival: Older persons with multiple chronic conditions' unplanned readmission experiences: A mixed methods systematic review.

The aim of this study was to create a holistic understanding of the psychosocial processes of older persons with multiple chronic conditions' experience with unplanned readmission experiences within 3... Mixed methods systematic review.... Six electronic databases (Ovid MEDLINE (R) All 1946-present, Scopus, CINAHL, Embase, PsychINFO and Web of Science).... Peer-reviewed articles published between 2010 and 2021 and addressed study aims (n = 6116) were screened. Studies were categorised by method: qualitative and quantitative. Qualitative data synthesis u... Ten articles (n = 5 qualitative; n = 5 quantitative) were included. 'Safeguarding survival' described older persons' unplanned readmission experience. Older persons experienced three psychosocial proc... Older persons felt more unsafe as their symptoms increased in intensity and unmanageability. Unplanned readmission was an action older persons required to safeguard their recovery and survival.... Nurses play a critical role in assessing and addressing factors that influence older persons' unplanned readmission. Identifying older persons' knowledge about chronic conditions, discharge planning, ... PRISMA guidelines.... No patient or public contribution due to design....

Methods and operational aspects of human-centred design into research processes for individuals with multiple chronic conditions: A survey study.

To examine ways in which human-centred design was integrated into a nursing school's research processes involving individuals with multiple chronic conditions.... Cross-sectional survey study.... Three surveys were sent out, with surveys 1 and 2 involving faculty who had worked closely with design strategists and survey 3 as a school-wide survey eliciting experience with human-centred design, ... Survey respondents (n = 7 for surveys 1 and 2 and n = 36 for survey 3) had no or minimal experience with human-centred design. Faculty respondents indicated it helped engaging various stakeholders, pa...

Ethnic and geographic variations in multiple chronic conditions among community-dwelling older people in Xinjiang: a cross-sectional study.

Multiple chronic conditions (MCC) refer to the presence of two or more chronic diseases. The incidence of MCC is higher in older people, and increases with age. Studies have shown an association betwe... A multilevel random sampling method was employed to perform an epidemiological survey in community-dwelling older adults in southern, northern, and eastern Xinjiang between January 2019 to December 20... Our analysis demonstrated that hypertension (51.5%), obesity (27.0%), diabetes (16.9%), heart disease (8.2%), and anxiety/depression (4.5%) were the five main chronic diseases in Xinjiang. The prevale... There are ethnic and geographic variations in multiple chronic conditions among community-dwelling older people in Xinjiang. The older adults living in northern and southern Xinjiang and Han, Kazakh, ...

The influence of dyad sex combination on patient self-care and caregiver contribution to self-care in multiple chronic conditions: An observational study.

We know that patient and caregiver sex influence patient self-care and caregiver contribution to self-care in multiple chronic conditions. However, the role of dyad sex combination (e.g., male patient... Multicentre cross-sectional study.... We enrolled patients with multiple chronic conditions and caregiver dyads in outpatient and community settings from April 2017 to December 2019. We used the Self-Care of Chronic Illness Inventory and ... We recruited 540 patient-caregiver dyads. Male patients cared by female caregivers performed higher self-care maintenance compared to female patients cared by female caregivers. Female caregivers cari... Clinicians should consider the influence of patient and caregiver sex combination on self-care and caregiver contribution to self-care in multiple chronic conditions to provide tailored interventions.... Healthcare professionals should consider the patient and caregiver sex combination in the dyad to tailor better interventions aimed at improving patient self-care and caregiver contribution to self-ca...